Full-Time

Principal Biostatistician FSP

Rwe

Posted on 4/16/2025

IQVIA

IQVIA

10,001+ employees

Analytics and research for life sciences

Compensation Overview

$131.3k - $243.9k/yr

+ Incentive Plans + Bonuses

Senior, Expert

Company Historically Provides H1B Sponsorship

Durham, NC, USA

Home-based remote working opportunities; candidates can be based in the U.S. or Canada.

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
SAS
Machine Learning
Data Analysis
Requirements
  • In-depth knowledge of RWE databases, including large administrative claims data, EMR, disease registries, and clinical trial data.
  • Demonstrated ability in evaluation and development of RWE from conceptualization through application.
  • Ability to execute statistical analysis plans using advanced programming techniques to perform detailed and complex analyses relevant to real-world evidence.
  • Ability to effectively interpret and communicate research results to internal and external audiences.
  • Understanding of ICH GCP and E9 as well as general knowledge of industry practices and standards.
  • Knowledge of global regulatory and HTA requirements for RWE.
  • PhD in Statistics, Biostatistics, or related field with 5+ years industry experience or MS in Statistics, Biostatistics, or related field with 7+ years of industry experience.
  • Experience leading secondary data analysis, including medical claims, electronic medical records, chart reviews, and registries.
  • Excellent organizational skills and proven ability to effectively lead multiple projects to successful completion.
  • SME-level proficiency in SAS programming tailored to handle complex inclusion and exclusion criteria, conduct propensity score matching, and develop outcome metrics.
  • Expertise in R is also valued.
  • Experience with CDISC ADAM datasets.
  • Extensive working experience with stakeholders such as medical affairs and health economics.
Responsibilities
  • Collaborate with multi-disciplinary project teams to establish project goals and timelines.
  • Serves as statistical lead and represents Biometrics on health outcomes and epidemiology studies.
  • Serves as subject matter expert for RWE/HEOR/HTA research design, methodologies, data sources, analytic techniques, and reporting.
  • Writes statistical analysis plans.
  • Provides strategic and tactical support for cross-functional RWE development for regulators, payers, and clinicians.
  • Leverages administrative claims, electronic medical records, registries, or other real-world data and recommends optimal study designs.
  • Selects and implements appropriate analytical methods including statistical models or machine learning models to align with overall business objectives.
  • Develops high quality study protocols, statistical analysis plans, study reports, and other study documents.
  • Identifies innovation opportunities for the use of RWD.
  • Establishes effective communication with various internal stakeholders to understand and support the strategy for when and how to use RWD.
  • Commitment to maintaining the highest standards of data accuracy and integrity by implementing rigorous quality control processes throughout the data handling and analysis phases.
  • Demonstrated ability to quickly adapt to new requirements and efficiently handle ad-hoc requests.
Desired Qualifications
  • Expertise in R is also valued.

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their main product, IQVIA Connected Intelligence™, utilizes large datasets and technology to offer quick insights that help clients speed up the development and marketing of new medical treatments. This service is designed to improve healthcare outcomes by connecting various aspects of healthcare. What sets IQVIA apart from its competitors is its strong focus on patient privacy, employing advanced technologies to protect individual data. The company's goal is to enhance understanding of diseases and human behaviors, ultimately contributing to the development of cures.

Company Size

10,001+

Company Stage

IPO

Headquarters

Durham, North Carolina

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven patient engagement tools improve healthcare experiences and outcomes.
  • Blockchain in clinical trials enhances data security and transparency.
  • Real-world evidence use in regulatory submissions boosts demand for IQVIA's analytics services.

What critics are saying

  • Competition from AI-driven solutions by companies like Nvidia may impact market share.
  • Rapid medical innovation may strain IQVIA's resources for timely guidance.
  • Med-R1 8B adoption may face challenges against larger competitor models.

What makes IQVIA unique

  • IQVIA's Med-R1 8B LLM outperforms larger models in medical reasoning tasks.
  • Site Lab Navigator automates lab workflows, enhancing clinical trial efficiency.
  • IQVIA's AI Assistant won the 2024 PM360 Innovation Award for AI.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Life Insurance

Flexible Work Hours

Paid Vacation

Wellness Program

401(k) Retirement Plan

Company News

BioPharmaTrend
Apr 7th, 2025
IQVIA Introduces a Compact Medical Reasoning LLM Outscoring Larger Models

IQVIA has launched Med-R1 8B, a medical reasoning large language model (LLM) designed to assist healthcare professionals in interpreting complex clinical data and scientific literature.

PR Newswire
Mar 26th, 2025
'Business Of Life Sciences And Healthcare For Leaders' Forthcoming From Umd Smith Executive Education

COLLEGE PARK, Md., March 26, 2025 /PRNewswire/ -- Registration is open for "Business of Life Sciences and Healthcare for Leaders" (B-LSHC) — an immersive five-day program focused on leadership development and honing critical-thinking and problem-solving skills in medical product development presented by Smith Executive Education at the University of Maryland's Robert H. Smith School of Business.The in-person program takes place June 23-27, 2025, at Van Munching Hall on UMD's College Park campus and is designed for mid-to-advanced career professionals in the LSHC ecosystem including pharmaceutical, biotech and medical device industries; health policy; patient advocacy; regulators; investors; and leaders across medical and regulatory fields.Program sessions will begin at 8:30 a.m. each day "and end with a luminary keynote speaker who will inspire and challenge participants to think outside the box toward the goals of creating innovative solutions for some of our most challenging problems in the LSHC ecosystem," says Wendy Sanhai, PhD, professor of the practice in management and organization for the Smith School and one of the workshop's organizers.Participants will learn from world-renowned faculty, regulatory experts and industry leaders on how to make informed decisions at crucial stages of medical product (drugs, biologics and medical devices) development – from R&D and regulatory submission to commercial launch and reimbursement. And, through expert-led sessions, dynamic capstone project discussions and case-study analysis, participants will sharpen their problem-solving and critical-thinking skills as they expand their professional network.Instructors, in addition to Sanhai, will include UMD and Smith faculty experts Balaji Padmanabhan, director of Smith's Center for Artificial Intelligence in Business; management and organization professors Jennifer Carson Marr, Oliver Schlake and Subra Tangirala; marketing professor Judy Frels; School of Public Health Dean Boris Lushniak; and School of Pharmacy Professor Joga Gobburu.The UMD experts will be joined by leading industry experts including former CEO of Scorpion Therapeutics Axel Hoos, IntoValue CEO Marion Couch, Deloitte Principals Juergen Klenk, Candy Lurken and Mathias Cousin; Euclidean Life Science Advisors President Kenneth Moch; Licensing IP negotiator Steve Ferguson; leaders from IQVIA and former FDA leaders.Participants will:Sharpen problem-solving, leadership and critical-thinking skillsCultivate holistic thinking and multidisciplinary approaches for real-world problems in the LSHC ecosystemBuild upon lessons learned and best practices from regulatory experts, industry luminaries and academic leadersExpand their professional networkIdentify major milestones, potential challenges, risks and mitigation strategies across medical product development pathways in R&D, regulatory submission, product launch and commercializationExecute critical steps in license negotiations and technology transfer processesParticipants should have at least a bachelor's degree and five years of working experience in any LSHC field.Scholarships are available, including for nonprofits, government professionals and veterans. Discounts are available for organizations with multiple participants. Information sessions via Zoom are set for 1-2 p.m

HR Tech Wire
Mar 10th, 2025
IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences industries, has been named to the "Leaders" category of the IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions and Consulting Services 2024 Vendor Assessment.

Life Sciences British Columbia
Mar 4th, 2025
IQVIA Laboratories Launches Site Lab Navigator with Breakthrough e-Requisition Innovation to Transform Clinical Trials

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials.

IQVIA
Mar 4th, 2025
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

RESEARCH TRIANGLE PARK, N.C. - March 4, 2025 - IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an advanced suite of solutions that automates and streamlines lab workflows for clinical trial sponsors and investigator sites.